TSXV - Free Realtime Quote CAD

Reliq Health Technologies Inc. (RHT.V)

0.2150 0.0000 (0.00%)
As of January 16 at 3:59 PM EST. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
6/30/2022
6/30/2021
6/30/2020
Total Revenue
10,415.8760
8,551.8070
1,462.1650
1,143.0270
Cost of Revenue
4,099.0010
3,250.5030
604.2110
968.6710
Gross Profit
6,316.8750
5,301.3040
857.9540
174.3560
Operating Expense
11,102.5500
13,597.0520
12,490.6960
11,340.3150
Operating Income
-4,785.6750
-8,295.7480
-11,632.7420
-11,165.9590
Net Non Operating Interest Income Expense
126.3690
41.3280
-46.6190
-36.1930
Other Income Expense
575.7720
83.4390
-101.1940
79.7950
Pretax Income
-4,083.5340
-8,170.9810
-11,780.5550
-11,122.3570
Net Income Common Stockholders
-4,083.5240
-8,170.9810
-11,780.5550
-11,122.3570
Diluted NI Available to Com Stockholders
-4,083.5240
-8,170.9810
-11,780.5550
-11,122.3570
Basic EPS
-0.02
-0.04
-0.07
-0.08
Diluted EPS
-0.02
-0.04
-0.07
-0.08
Basic Average Shares
186,266.3960
183,085.9290
157,891.1200
135,219.3170
Diluted Average Shares
186,266.3960
183,085.9290
157,891.1200
135,219.3170
Total Operating Income as Reported
-4,816.6940
-8,331.0280
-11,679.3610
--
Total Expenses
15,201.5510
16,847.5550
13,094.9070
12,308.9860
Net Income from Continuing & Discontinued Operation
-4,083.5240
-8,170.9810
-11,780.5550
-11,122.3570
Normalized Income
-4,659.2960
-8,254.4200
-11,679.3610
-11,202.1520
Interest Income
157.3980
76.6080
--
--
Interest Expense
31.0290
35.2800
46.6190
36.1930
Net Interest Income
126.3690
41.3280
-46.6190
-36.1930
EBIT
-4,052.5050
-8,135.7010
-11,733.9360
-11,086.1640
EBITDA
-3,936.3840
-8,020.4140
-11,608.1800
-10,640.7540
Reconciled Cost of Revenue
4,099.0010
3,250.5030
604.2110
968.6710
Reconciled Depreciation
116.1210
115.2870
125.7560
445.4100
Net Income from Continuing Operation Net Minority Interest
-4,083.5240
-8,170.9810
-11,780.5550
-11,122.3570
Total Unusual Items Excluding Goodwill
575.7720
83.4390
-101.1940
79.7950
Total Unusual Items
575.7720
83.4390
-101.1940
79.7950
Normalized EBITDA
-4,512.1560
-8,103.8530
-11,506.9860
-10,720.5490
6/30/2020 - 7/10/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers